HRP20090101T3 - N-(1h-indolyl)-h-indole-2-carboxamide derivatives, their preparation and their therapeutic use - Google Patents
N-(1h-indolyl)-h-indole-2-carboxamide derivatives, their preparation and their therapeutic useInfo
- Publication number
- HRP20090101T3 HRP20090101T3 HR20090101T HRP20090101T HRP20090101T3 HR P20090101 T3 HRP20090101 T3 HR P20090101T3 HR 20090101 T HR20090101 T HR 20090101T HR P20090101 T HRP20090101 T HR P20090101T HR P20090101 T3 HRP20090101 T3 HR P20090101T3
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- group
- cycloalkyl
- fluoroalkyl
- aryl
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 9
- 125000003118 aryl group Chemical group 0.000 abstract 5
- 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
- -1 C (O) NR1R2 Chemical group 0.000 abstract 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- FQUYSHZXSKYCSY-UHFFFAOYSA-N 1,4-diazepane Chemical compound C1CNCCNC1 FQUYSHZXSKYCSY-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 abstract 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000004428 fluoroalkoxy group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Biotechnology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0408652A FR2874015B1 (fr) | 2004-08-05 | 2004-08-05 | Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| PCT/FR2005/002014 WO2006024776A1 (fr) | 2004-08-05 | 2005-08-02 | Derives de n-(1 h-indolyl)-i h-ind0le-2-carb0xamides, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20090101T3 true HRP20090101T3 (en) | 2009-03-31 |
Family
ID=34950701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20090101T HRP20090101T3 (en) | 2004-08-05 | 2009-02-17 | N-(1h-indolyl)-h-indole-2-carboxamide derivatives, their preparation and their therapeutic use |
Country Status (38)
| Country | Link |
|---|---|
| US (3) | US7384969B2 (pl) |
| EP (1) | EP1776340B1 (pl) |
| JP (1) | JP5100381B2 (pl) |
| KR (1) | KR101215162B1 (pl) |
| CN (1) | CN101010297B (pl) |
| AR (1) | AR050283A1 (pl) |
| AT (1) | ATE416160T1 (pl) |
| AU (1) | AU2005279085B2 (pl) |
| BR (1) | BRPI0513087A (pl) |
| CA (1) | CA2576727C (pl) |
| CR (1) | CR8889A (pl) |
| CY (1) | CY1108816T1 (pl) |
| DE (1) | DE602005011450D1 (pl) |
| DK (1) | DK1776340T3 (pl) |
| EA (1) | EA011714B1 (pl) |
| EC (1) | ECSP077215A (pl) |
| ES (1) | ES2318542T3 (pl) |
| FR (1) | FR2874015B1 (pl) |
| HK (1) | HK1110308A1 (pl) |
| HR (1) | HRP20090101T3 (pl) |
| IL (1) | IL180911A (pl) |
| MA (1) | MA28845B1 (pl) |
| ME (1) | ME01663B (pl) |
| MX (1) | MX2007001436A (pl) |
| MY (1) | MY139286A (pl) |
| NO (1) | NO340060B1 (pl) |
| NZ (1) | NZ552924A (pl) |
| PE (1) | PE20060557A1 (pl) |
| PL (1) | PL1776340T3 (pl) |
| PT (1) | PT1776340E (pl) |
| RS (1) | RS50853B (pl) |
| SI (1) | SI1776340T1 (pl) |
| TN (1) | TNSN07041A1 (pl) |
| TW (1) | TWI360538B (pl) |
| UA (1) | UA90483C2 (pl) |
| UY (1) | UY29046A1 (pl) |
| WO (1) | WO2006024776A1 (pl) |
| ZA (1) | ZA200700999B (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2874015B1 (fr) * | 2004-08-05 | 2006-09-15 | Sanofi Synthelabo | Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2880625B1 (fr) * | 2005-01-07 | 2007-03-09 | Sanofi Aventis Sa | Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2888847B1 (fr) | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique |
| PE20080145A1 (es) * | 2006-03-21 | 2008-02-11 | Janssen Pharmaceutica Nv | Tetrahidro-pirimidoazepinas como moduladores de trpv1 |
| FR2910473B1 (fr) * | 2006-12-26 | 2009-02-13 | Sanofi Aventis Sa | Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique. |
| FR2911604B1 (fr) * | 2007-01-19 | 2009-04-17 | Sanofi Aventis Sa | Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| EA020332B1 (ru) * | 2007-08-10 | 2014-10-30 | Х. Лундбекк А/С | Аналоги гетероариламидов |
| WO2009078999A1 (en) | 2007-12-17 | 2009-06-25 | Janssen Pharmaceutica N.V. | Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
| FR2926554B1 (fr) * | 2008-01-22 | 2010-03-12 | Sanofi Aventis | Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique |
| FR2926556B1 (fr) * | 2008-01-22 | 2010-02-19 | Sanofi Aventis | Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique |
| FR2926555B1 (fr) | 2008-01-22 | 2010-02-19 | Sanofi Aventis | Derives bicycliques de carboxamides azabicycliques, leur preparation et leur application en therapeutique |
| US20100210682A1 (en) * | 2009-02-19 | 2010-08-19 | Abbott Laboratories | Repeated Dosing of TRPV1 Antagonists |
| FR3007850B1 (fr) | 2013-06-28 | 2015-07-17 | Probayes | Systeme de prediction de temperature |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5846990A (en) * | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
| NZ330818A (en) * | 1996-02-13 | 2000-05-26 | Abbott Lab | Benzo-1, 3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| EP1003740A2 (en) * | 1997-08-04 | 2000-05-31 | Abbott Laboratories | Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagoists |
| EP1314733A1 (en) * | 2001-11-22 | 2003-05-28 | Aventis Pharma Deutschland GmbH | Indole-2-carboxamides as factor Xa inhibitors |
| PL373484A1 (pl) * | 2001-12-10 | 2005-09-05 | Amgen Inc. | Ligandy receptora waniloidowego oraz ich medycznezastosowania |
| MXPA04011472A (es) * | 2002-05-22 | 2005-02-14 | Amgen Inc | Derivados de amino-piridina, piridina y piridazina para usarse como ligandos del receptor vaniloide para el tratamiento del dolor. |
| US20060183753A1 (en) * | 2002-12-20 | 2006-08-17 | Bayer Healthcare Ag | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
| ATE450533T1 (de) | 2003-02-14 | 2009-12-15 | Glaxo Group Ltd | Carboxamidderivate |
| US7544803B2 (en) * | 2004-01-23 | 2009-06-09 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| FR2874015B1 (fr) * | 2004-08-05 | 2006-09-15 | Sanofi Synthelabo | Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2880625B1 (fr) * | 2005-01-07 | 2007-03-09 | Sanofi Aventis Sa | Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique |
-
2004
- 2004-08-05 FR FR0408652A patent/FR2874015B1/fr active Active
-
2005
- 2005-02-08 UA UAA200702276A patent/UA90483C2/uk unknown
- 2005-08-02 CA CA2576727A patent/CA2576727C/fr active Active
- 2005-08-02 WO PCT/FR2005/002014 patent/WO2006024776A1/fr active Application Filing
- 2005-08-02 KR KR1020077002714A patent/KR101215162B1/ko not_active IP Right Cessation
- 2005-08-02 AT AT05793766T patent/ATE416160T1/de active
- 2005-08-02 SI SI200530600T patent/SI1776340T1/sl unknown
- 2005-08-02 ME MEP-2009-366A patent/ME01663B/me unknown
- 2005-08-02 PL PL05793766T patent/PL1776340T3/pl unknown
- 2005-08-02 AU AU2005279085A patent/AU2005279085B2/en not_active Ceased
- 2005-08-02 ZA ZA200700999A patent/ZA200700999B/xx unknown
- 2005-08-02 RS RSP-2009/0089A patent/RS50853B/sr unknown
- 2005-08-02 PT PT05793766T patent/PT1776340E/pt unknown
- 2005-08-02 EP EP05793766A patent/EP1776340B1/fr active Active
- 2005-08-02 DE DE602005011450T patent/DE602005011450D1/de active Active
- 2005-08-02 JP JP2007524371A patent/JP5100381B2/ja not_active Expired - Fee Related
- 2005-08-02 MX MX2007001436A patent/MX2007001436A/es active IP Right Grant
- 2005-08-02 BR BRPI0513087-5A patent/BRPI0513087A/pt not_active Application Discontinuation
- 2005-08-02 DK DK05793766T patent/DK1776340T3/da active
- 2005-08-02 CN CN2005800296989A patent/CN101010297B/zh not_active Expired - Fee Related
- 2005-08-02 UY UY29046A patent/UY29046A1/es not_active Application Discontinuation
- 2005-08-02 EA EA200700400A patent/EA011714B1/ru not_active IP Right Cessation
- 2005-08-02 ES ES05793766T patent/ES2318542T3/es active Active
- 2005-08-02 NZ NZ552924A patent/NZ552924A/en not_active IP Right Cessation
- 2005-08-03 PE PE2005000900A patent/PE20060557A1/es not_active Application Discontinuation
- 2005-08-03 MY MYPI20053619A patent/MY139286A/en unknown
- 2005-08-04 TW TW094126541A patent/TWI360538B/zh not_active IP Right Cessation
- 2005-08-04 AR ARP050103236A patent/AR050283A1/es not_active Application Discontinuation
-
2007
- 2007-01-18 US US11/624,406 patent/US7384969B2/en not_active Expired - Fee Related
- 2007-01-23 IL IL180911A patent/IL180911A/en not_active IP Right Cessation
- 2007-01-29 EC EC2007007215A patent/ECSP077215A/es unknown
- 2007-02-01 CR CR8889A patent/CR8889A/es unknown
- 2007-02-05 TN TNP2007000041A patent/TNSN07041A1/fr unknown
- 2007-03-02 MA MA29730A patent/MA28845B1/fr unknown
- 2007-03-02 NO NO20071198A patent/NO340060B1/no not_active IP Right Cessation
-
2008
- 2008-01-18 HK HK08100693.2A patent/HK1110308A1/xx not_active IP Right Cessation
- 2008-04-25 US US12/109,388 patent/US7582671B2/en not_active Expired - Fee Related
-
2009
- 2009-02-17 HR HR20090101T patent/HRP20090101T3/xx unknown
- 2009-02-19 CY CY20091100191T patent/CY1108816T1/el unknown
- 2009-07-21 US US12/506,322 patent/US7781477B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20090101T3 (en) | N-(1h-indolyl)-h-indole-2-carboxamide derivatives, their preparation and their therapeutic use | |
| RS51888B (en) | N- (PHENYL (PIPERIDIN-2-IL) METHYL) BENZAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY | |
| MEP12608A (en) | Derivatives of n-[phenyl (pyrrolidine-2-yl) methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics | |
| MEP22008A (en) | Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics | |
| AR055878A1 (es) | Derivados de ciclopropanocarboxamida | |
| HRP20080339T3 (en) | N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors | |
| AR049739A1 (es) | Derivados de aril-piridina | |
| HUP0402507A2 (hu) | N(fenilszulfonil)glicin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények | |
| RS50980B (sr) | Derivati n-hidroksiamida i njihova upotreba | |
| ES2195571T3 (es) | Nuevos benzonaftiridin-n-oxidos. | |
| BRPI0407501A (pt) | glicolipìdeos e método sintético dos mesmos bem como seus intermediários sintéticos, e método sintético dos mesmos | |
| PE20070751A1 (es) | Derivados de isoxazolidina como inhibidores de la interaccion de proteinas bcl | |
| AR052866A1 (es) | Fenil-metanonas monociclicas sustituidas | |
| HRP20080311T3 (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
| HUP0204399A2 (en) | Pteridine compounds for the treatment of psoriasis, process for their preparation, pharmaceutical compositions containing them and their use | |
| RS52702B (en) | CARBASOL UNITS AND THERAPEUTIC USE OF THE COMPOUNDS | |
| HRP20021023B1 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders | |
| HRP20050775A2 (en) | Quinolinone/benzoxazinone derivatives and uses thereof | |
| YU39698A (sh) | Hinoksalindioni | |
| HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
| YU40998A (sh) | Derivati supstituisanog 1,2,3,4-tetrahidronaftalina | |
| HUP0303568A2 (hu) | Benzotiofénszármazékok, eljárás előállításukra és alkalmazásuk | |
| BRPI0511581A (pt) | derivados de tetrahidroisoquinolilsulfonamidas, sua preparação e sua utilização em terapêutica | |
| TW200612931A (en) | Substituted biphenyl derivatives | |
| RS51233B (sr) | Derivati n-(arilalkil)-1h-pirolopiridin-2-karboksamida, njihovo dobijanje i upotreba |